Catalyst Pharmaceuticals: A 30.8% Better Bargain Than When Denkhaus Bought

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 8, Catalyst Pharmaceuticals Inc's Director, Donald A..